This ratio implies that the company will never grow NOPAT from its current level.
This valuation implies 19% growth in NOPAT compounded annually over the next 15 years.
This valuation implies NOPAT growth of 8% compounded annually for the next 19 years.
This ratio implies that ACN will never grow NOPAT from its current level.
This valuation implies a 17% growth in NOPAT compounded annually over the next 17 years.
This valuation implies that PGR will never grow NOPAT from its current level.
Its current valuation implies a 7% NOPAT CAGR over the next eight years.
It has grown after tax profit ( NOPAT) by 4% compounded annually for the past 13 years.
This ratio means the market is expecting LXK to experience a permanent decline of 70% in NOPAT.
The company has grown after tax profit ( NOPAT) by 10% compounded annually for the past 13 years.
FORBES: Go For XLI And UPS When Buying Into Industrial Sector
This valuation implies the company will generate 21% NOPAT growth compounded annually for the next 16 years.
All the while, the business has generated a NOPAT CAGR of 7% over the last 14 years.
To justify this price, the company must grow after-tax profit ( NOPAT) by 6% for the next 14 years.
Since 1998, it has grown after-tax profit ( NOPAT) by 8% compounded annually.
FORBES: Good Time To Get Caterpillar, IBM And ETFs That Hold Them
This ratio implies that the market expects FLR to grow NOPAT by only 10% and then never grow again.
This valuation implies the company will grow its NOPAT at over 20% compounded annually for more than 20 years.
FORBES: SanDisk Looks Solid Among Holdings Of Large-Cap Growth Funds
This high ROIC has been largely driven by a 15% CAGR in after-tax cash flow ( NOPAT) since 1998.
FORBES: Large-Cap Blend Funds Need More Microsoft, Less BofA
Expecting zero growth from a company that has grown NOPAT at 7% compounded annually since 1998 seems overly pessimistic.
This company has grown its after-tax cash flow ( NOPAT) by 5% compounded annually for the last 13 fiscal years.
FORBES: Better Off Buying Individual Utes Than Utility Sector ETFs
It has not had a year where NOPAT declined since at least 2001, as far back as our model goes.
This expectation seems overly optimistic for a company with a declining NOPAT and no track record of economic profitability.
This share price results in a price to economic book value ratio of 1.0, implying no future growth in NOPAT.
The last time IBM failed to grow NOPAT was in 2005.
FORBES: Good Time To Get Caterpillar, IBM And ETFs That Hold Them
This long-term decline in NOPAT, combined with growing asset write-downs and consistently large off balance sheet debt, indicates a company with serious issues.
To justify its current share price, Zale would have to grow after-tax profit ( NOPAT) by 4% compounded annually for the next nine years.
Even though the cigarette industry as a whole is clearly on a downward trend, MO has grown NOPAT by 10% compounded annually over the past four years.
Those are high expectations for a company that managed only 8% NOPAT growth over the past decade and whose ROIC declined in the last reported fiscal year.
FORBES: Rating Breakdown: Best & Worst ETFs & Mutual Funds By Sector
This acquisition spending does not appear to be aiding growth in the way management hoped, as PX saw after-tax profit ( NOPAT) increase by a paltry 2.6% in 2012.
应用推荐